PMLiVEThe European patent for Pfizer's blockbuster cholesterol drug, Lipitor (atorvastatin), could be extended by six months due to new paediatric data concerning the treatment. According to the Financial Times, the extended exclusivity to May 2012 for what …For more information, please visit: http://www.pmlive.com/find_an_article/allarticles/categories/General/2011/july_2011/news/eu_patent_extension_for_pfizers_lipitor
Inttranews – Daily News Site for Linguists